Neuromedin N (rat, mouse, porcine, canine)Neurotensin-like peptide CAS# 92169-45-4 |
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products
| Cas No. | 92169-45-4 | SDF | Download SDF |
| PubChem ID | 9940301 | Appearance | Powder |
| Formula | C38H63N7O8 | M.Wt | 745.96 |
| Type of Compound | N/A | Storage | Desiccate at -20°C |
| Solubility | H2O : 50 mg/mL (67.03 mM; Need ultrasonic) | ||
| Sequence | KIPYIL | ||
| Chemical Name | (2S)-2-[[(2S,3S)-2-[[(2S)-2-[[(2S)-1-[(2S,3S)-2-[[(2S)-2,6-diaminohexanoyl]amino]-3-methylpentanoyl]pyrrolidine-2-carbonyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-methylpentanoyl]amino]-4-methylpentanoic acid | ||
| SMILES | CCC(C)C(C(=O)NC(CC(C)C)C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)NC(=O)C2CCCN2C(=O)C(C(C)CC)NC(=O)C(CCCCN)N | ||
| Standard InChIKey | RZMLVIHXZGQADB-YLUGYNJDSA-N | ||
| Standard InChI | InChI=1S/C38H63N7O8/c1-7-23(5)31(36(50)42-29(38(52)53)20-22(3)4)43-34(48)28(21-25-14-16-26(46)17-15-25)41-35(49)30-13-11-19-45(30)37(51)32(24(6)8-2)44-33(47)27(40)12-9-10-18-39/h14-17,22-24,27-32,46H,7-13,18-21,39-40H2,1-6H3,(H,41,49)(H,42,50)(H,43,48)(H,44,47)(H,52,53)/t23-,24-,27-,28-,29-,30-,31-,32-/m0/s1 | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
| Description | Endogenous neurotensin-like neuropeptide, originally isolated from porcine spinal cord. Binds to neurotensin receptors (IC50 = 16.7 nM for inhibition of [Trp11]-NT binding to rat brain receptors). Regulates guinea pig intestinal smooth muscle contraction and produces hypotension in rats. Also induces hypothermia following central administration in rats in vivo. |
Neuromedin N (rat, mouse, porcine, canine) Dilution Calculator
Neuromedin N (rat, mouse, porcine, canine) Molarity Calculator
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Cysteine Protease inhibitor
Catalog No.:BCC5301
CAS No.:921625-62-9
- Fmoc-D-Lys(Boc)-OH
Catalog No.:BCC3526
CAS No.:92122-45-7
- ent-16-Kaurene-3beta,15beta,18-triol
Catalog No.:BCN6624
CAS No.:921211-29-2
- 4'-Methoxypuerarin
Catalog No.:BCN2901
CAS No.:92117-94-7
- Schisanlactone C
Catalog No.:BCN3314
CAS No.:92051-27-9
- Schisanlactone D
Catalog No.:BCN3247
CAS No.:92051-26-8
- Tenacigenoside A
Catalog No.:BCN4458
CAS No.:920502-42-7
- P276-00
Catalog No.:BCC4415
CAS No.:920113-03-7
- Influenza Hemagglutinin (HA) Peptide
Catalog No.:BCC2563
CAS No.:92000-76-5
- 4-Biphenylcarboxylic acid
Catalog No.:BCC8701
CAS No.:92-92-2
- 4-Acetylbiphenyl
Catalog No.:BCC8673
CAS No.:92-91-1
- 4,4'-Biphenol
Catalog No.:BCC8654
CAS No.:92-88-6
- Capecitabine-2',3'-cyclic carbonate
Catalog No.:BCC8903
CAS No.:921769-65-5
- Phosphocreatine disodium salt
Catalog No.:BCC7918
CAS No.:922-32-7
- 12-O-Tiglylphorbol-13-isobutyrate
Catalog No.:BCN2512
CAS No.:92214-54-5
- SCH 529074
Catalog No.:BCC6131
CAS No.:922150-11-6
- GlcNAcstatin
Catalog No.:BCC5334
CAS No.:922163-64-2
- 5,6-Desmethylenedioxy-5-methoxyaglalactone
Catalog No.:BCN7639
CAS No.:922169-96-8
- Syringin pentaacetate
Catalog No.:BCN4459
CAS No.:92233-55-1
- Daphnilongeridine
Catalog No.:BCN4460
CAS No.:922522-15-4
- (±)-MDMA hydrochloride
Catalog No.:BCC5965
CAS No.:92279-84-0
- Sanggenon N
Catalog No.:BCN4846
CAS No.:92280-12-1
- 3-O-Methyl-3-methoxymaxterone
Catalog No.:BCC8639
CAS No.:92282-70-7
- Refametinib
Catalog No.:BCC4276
CAS No.:923032-37-5
Hypothermic effect of neuromedin N in mice and its potentiation by peptidase inhibitors.[Pubmed:3416919]
Eur J Pharmacol. 1988 Jun 22;151(1):117-21.
The intracerebroventricular administration of neuromedin N (from 50 ng to 5 micrograms) elicited a dose- and time-dependent hypothermia in mice. Two aminopeptidase inhibitors, bestatin (50 micrograms) and puromycin (50 micrograms), the endopeptidase 24.11 inhibitor, thiorphan (10 micrograms), and the angiotensin-converting enzyme inhibitor, captopril (50 micrograms), were tested for their ability to potentiate the neuromedin N-induced hypothermia. Only bestatin significantly increased the response to the peptide. In addition, thiorphan, though devoid of effect on the neuromedin N-induced hypothermia when given alone, further potentiated the response elicited by neuromedin N and bestatin. The combinations of puromycin/thiorphan and bestatin/captopril did not potentiate the neuromedin N-induced hypothermia.
Neuromedin N: high affinity interaction with brain neurotensin receptors and rapid inactivation by brain synaptic peptidases.[Pubmed:3019713]
Eur J Pharmacol. 1986 Jul 31;126(3):239-44.
Neuromedin N (NN) is a novel neurotensin (NT)-like hexapeptide recently isolated from porcine spinal cord. NN competitively inhibited the binding of monoiodinated [Trp11]NT to rat brain synaptic membranes with a 19-fold lower potency than NT. In the presence of 1 mM 1,10-phenanthroline or 10 microM bestatin, the potency of NN relative to NT was increased about 5-fold. NN was readily degraded by rat brain synaptic membranes, and NN-(2-6) was the major degradation product. NN-(2-6) did not bind to NT receptors at concentrations up to 1 microM whether or not peptidase inhibitors were present in the binding assay. The rate of degradation by synaptic membranes was nearly 2.5 times higher for NN than for NT. NN degradation by membranes was totally prevented by 1,10-phenanthroline and markedly inhibited by bestatin. The presence of NN in the central nervous system, its high potency to interact with brain NT receptors and its rapid inactivation by brain synaptic peptidases make it a potential neurotransmitter candidate acting at the NT receptor.
Neuromedin N: a novel neurotensin-like peptide identified in porcine spinal cord.[Pubmed:6547840]
Biochem Biophys Res Commun. 1984 Jul 31;122(2):542-9.
A novel neurotensin-like peptide, designated neuromedin N, has been isolated from porcine spinal cord by using a bioassay for a stimulant effect on guinea pig ileum. By microsequencing, the amino acid sequence of the peptide has been determined to be Lys-Ile-Pro-Tyr-Ile-Leu, which is found to be quite homologous to the COOH-terminal sequence of neurotensin. This structure has been confirmed by synthesis. Neuromedin N exhibits a contractile activity on guinea pig ileum and induces a hypotensive response in the rat similar to that with neurotensin. These findings suggest that neuromedin N may be a new neuromediator or hormone with a specific spectrum of biological activity.
